Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: Methodological and preliminary clinical evaluation

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 2, 2005, Pages 202-209

  Di Serio, Francesca ^a,c   Amodio, Gianfranco ^a   Varraso, Lucia ^a   Campaniello, Maurizio ^a   Coluccia, Paola ^a   Trerotoli, Paolo ^b   Antonelli, Gianfranco ^a   Pansini, Nicola ^a  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c NONE   (Italy)

Author keywords

Acute myocardial infarction (AMI); Emergency department; Point of care testing (POCT); Troponin I

Indexed keywords

TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ASSAY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; EMERGENCY WARD; FEMALE; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL INFORMATION SYSTEM; HOSPITAL LABORATORY; HOSPITAL PERSONNEL; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; PERFORMANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUALITY CONTROL; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION; STAFF TRAINING;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; CORONARY DISEASE; EMERGENCIES; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 14944357252     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.035     Document Type: Article

References (32)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69. Eur Heart J 2000;21:1502-13.
2. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2000;102:1193-209.
3. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999;37:687-93.
4. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes RJ. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
5. Di Serio F, Antonelli G, Trerotoli P, Tampoia M, Matarrese M, Pansini N. Appropriateness of point-of-care testing (POCT) in an emergency department. Clin Chim Acta 2003;333:185-9.
6. Public Health Service Act. S353, 42 USC S263a, 1988.
7. US Department of Health and Human Services. Medicare, Medicaid and CLIA programs: regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Final rule. Fed Reg 1993; 58:5215-37.
8. National Committee for Clinical Laboratory Standards. Point-of-care in vitro diagnostic (IVD) testing; approved guideline. NCCLS guideline AST2-A. Wayne, PA: NCCLS, June 1999.
9. Hudson MP, Christenson RH, Newby LH, Kaplan AL, Ohman EG. Cardiac markers: point of care testing. Clin Chim Acta 1999;284:223-37.
10. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). IFCC Scientific Division Committee on Standardization of Markers of Cardiac Damage. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:174-8.
11. Panteghini M. The measurement of cardiac markers. Where should we focus? Am J Clin Pathol 2002; 118:354-61.
12. Wu AHB. Point-of-care testing for cardiac markers. Point Care 2002;1:39-41.
13. Singh P, Moll F, Lin SH, Ferzli C, Yu KS, Koski RK, et al. Starburst™ dendrimers: enhanced performance and flexibility for immunoassays. Clin Chem 1994;40:1845-9.
14. Heeschen C, Goldmann BU, Langenbrink L, Matschuck G, Hamm CW. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem 1999;45:1789-96.
15. Altinier S, Mion M, Cappelletti A, Zaninotto M, Plebani M. Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000;46:991-3.
16. Kim WJ, Laterza OF, Hock KG, Pierson-Perry JF, Kaminski DM, Mesguich M, et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002;48:1028-34.
17. Bodor GS, Porter S, Landt Y, Landenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992;38:2201-14.
18. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5-A. Wayne, PA: NCCLS, February 1999.
19. Geiger DU, Wu AHB, Apple FS, Jevans AW, Venge P, Olson MD et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002;48:869-76.
20. National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; proposed guideline. NCCLS guideline EP6-A. Wayne, PA: NCCLS, September 1986.
21. National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples; approved guideline. NCCLS guideline EP9-A. Wayne, PA: NCCLS, December 1995.
22. Kost GJ. Connectivity, the millennium challenge for point-of-care testing. Arch Pathol Lab Med 2000; 124:1108-10.
23. Kaminski D, Sivakoff S, McCormack B, Pierson-Perry J. Development and analytical performance of an improved method for cardiac troponin-I on the Dade Behring Dimension clinical chemistry system. Clin Chem 2001;47(Suppl):A211.
24. Martin RF. General Deming regression procedures for methods comparison studies. Clin Chem 1993;39:424-32.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
26. Di Serio F, Trerotoli P, Serio G, Varraso L, Pansini N. Analytical evaluation of an automated immunoassay for cardiac troponin I: the Vidas troponin I assay. Clin Chem Lab Meti 2003;41:1363-8.
27. Panteghini M, Pagani F, Yeo KJ, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assay at low-range concentration. Clin Chem 2004;50:327-32.
28. Christenson RH, Cervelli DR, Bauer RS, Gordon M. Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentration. Clin Biochem 2004;37:679-83.
29. Lamb LS. Responsibilities in point-of-care testing: an institutional perspective. Arch Pathol Lab Med 1995; 119:886-9.
30. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691-8.
31. Galvani M, Panteghini M, Ottani F, Cappelletti P, Chiarello F, Crea F, et al. "La nuova definizione di infarto miocardico" analisi dei documento di consenso ESC/ACC e riflessioni sulla applicabilità alla realtà sanitaria Italiana. Biochim Clin 2002;26:21-40.
32. Lee-Lewandrowski E, Corboy D, Lewandrowski K, Siclair J, McDermot S, Benzer TI. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center, impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 2003;127:456-60.